Hikal informs about unaudited financial results

24 Oct 2018 Evaluate

Hikal has informed that the meeting of the Board of Directors of the Company is scheduled on 01/11/2018, to consider and approve unaudited financial results for quarter ended 30th September 2018.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

194.00 -5.95 (-2.98%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×